Akron Children's Logo
Skip to main content
Close Tools Menu Icon

Operator:

330-543-1000

Questions or Referrals:
ASK CHILDREN‘S

Close Phone Menu Icon
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP

Full IRB Study Title:
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP

IRB Study ID: 23875646

See complete study information on clinicaltrials.gov.

Study Sponsor:

CSL Behring

 We are currently recruiting

If you are interested in this study or have questions about your child's eligibility, please contact:

Hilary Tonni, Rebecca D. Considine Research Institute: 330-543-4734

Who May Qualify:

Male or female patients 2 to <17 years of age with confirmed or possible chronic inflammatory demyelinating polyneuropathy (CIDP)

Who Does NOT Qualify:

Patients with:

  • History or family history of inherited neuropathy
  • Diagnosed developmental delay or regression
  • History of thrombotic episode
  • Known or suspected hypersensitivity to Privigen
  • Known allergic or other severe reactions to blood products
  • Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study
  • Pregnant or breastfeeding mother

Lead Investigator

Ian Rossman

Ian Rossman, MD, PhD

Pediatric Neurologist


NeuroDevelopmental Science CenterPediatric Neuromuscular ClinicPediatric NeurologyMitochondrial Center

More about this provider

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.